Johnson & Johnson to Participate in the UBS MedTech, Tools and Genomics Summit
NEW BRUNSWICK, N.J.–(BUSINESS WIRE)–
Johnson & Johnson (NYSE: JNJ) will participate in the UBS MedTech, Tools and Genomics Summit on Tuesday, August 15th, at the Waldorf Astoria Monarch Beach Resort & Club in Dana Point, CA. Celine Martin, Company Group Chairman Cardiovascular & Specialty Solutions Group (CSS), Anthony (Tony) Long, VP, Clinical Research, Medical Affairs, Preclinical Research and Jasmina Brooks, President Biosense Webster will represent the Company in a session scheduled at 2:00 pm (Eastern Time).
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.
A webcast replay will be available approximately 48-hrs after the live webcast.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230710327307/en/
Investor Contact:
[email protected]
Media Contact:
[email protected]
KEYWORDS: California New Jersey United States North America
INDUSTRY KEYWORDS: Genetics Health Cardiology Medical Devices
MEDIA:
| Logo |
 |